Advent Life Sciences LLP 13D and 13G filings for Aura Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 5:59 pm Purchase | 2021-12-31 | 13G | Aura Biosciences, Inc. AURA | Advent Life Sciences LLP | 2,023,857 6.900% | 2,023,857 (New Position) | Filing |